^
BIOMARKER:

AKR1C2 overexpression

i
Other names: AKR1C2, Aldo-Keto Reductase Family 1 Member C2, DD2, HAKRD, MCDR2, BABP, DDH2, DD, Dihydrodiol Dehydrogenase 2; Bile Acid Binding Protein; 3-Alpha Hydroxysteroid Dehydrogenase, Type III, Testicular 17,20-Desmolase Deficiency, Chlordecone Reductase Homolog HAKRD, 3-Alpha-HSD3, DD/BABP, DD-2, TDD, Aldo-Keto Reductase Family 1, Member C2 (Dihydrodiol Dehydrogenase 2; Bile Acid Binding Protein; 3-Alpha Hydroxysteroid Dehydrogenase, Type III), Dihydrodiol Dehydrogenase/Bile Acid-Binding Protein, Trans-1,2-Dihydrobenzene-1,2-Diol Dehydrogenase, Type III 3-Alpha-Hydroxysteroid Dehydrogenase, Type II Dihydrodiol Dehydrogenase, Pseudo-Chlordecone Reductase, Dihydrodiol Dehydrogenase 2, AKR1C-Pseudo, SRXY8, HBAB
Entrez ID:
News
Twitter
Trials
AKR1C2 overexpression
Breast Cancer
tamoxifen
Resistant: D – Preclinical